COGNITION THERAPEUTICS INC (CGTX) Stock Balance Sheet
USA - NASDAQ:CGTX - US19243B1026 - Common Stock
2.15 USD
-0.21 (-8.9%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 10.74M | 25.01M | 29.92M | 41.56M | 54.72M | |||
| Receivables | 6.29M | 2.69M | 1.28M | 3.67M | 2.27M | |||
| Other Current Assets | 2.02M | 1.86M | 3.02M | 2.41M | 2.00M | |||
| Total Current Assets | 19.05M | 29.55M | 34.22M | 47.65M | 58.99M | |||
| Non-Current Assets | ||||||||
| PPE Net | 573.00K | 679.00K | 941.00K | 1.05M | 150.00K | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 1.73M | N/A | |||
| Total Non-Current Assets | 573.00K | 679.00K | 941.00K | 2.78M | 150.00K | |||
| TOTAL ASSETS | 19.62M | 30.23M | 35.16M | 50.43M | 59.14M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 9.57M | 7.81M | 4.23M | 2.24M | 1.75M | |||
| Accounts Payable | 771.00K | 1.98M | 3.69M | 3.22M | 4.17M | |||
| Other Current Liabilities | 2.02M | 1.34M | 2.25M | 2.34M | 1.95M | |||
| Total Current Liabilities | 12.36M | 11.14M | 10.17M | 7.80M | 7.86M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 229.00K | 342.00K | 520.00K | 2.38M | 0.00 | |||
| Total Non-Current Liabilities | 229.00K | 342.00K | 520.00K | 2.38M | 0.00 | |||
| TOTAL LIABILITIES | 12.59M | 11.48M | 10.69M | 10.18M | 7.86M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -190.37M | -175.16M | -141.19M | -115.40M | -94.00M | |||
| Additional Paid In Capital | 197.34M | 193.85M | 165.83M | 155.82M | 145.45M | |||
| Common Shares | 65.00K | 60.00K | 32.00K | 30.00K | 20.00K | |||
| Other Shareholders' Equity | N/A | N/A | -195.00K | -200.00K | -200.00K | |||
| Shares Outstanding | 64.96M | 59.85M | 32.17M | 28.99M | 22.23M | |||
| Tangible Book Value per Share | 0.11 | 0.31 | 0.76 | 1.39 | 2.31 | |||
| Total Shareholders' Equity | 7.03M | 18.75M | 24.47M | 40.25M | 51.27M | |||
| TOTAL LIABILITIES AND EQUITY | 19.62M | 30.23M | 35.16M | 50.43M | 59.14M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.54 | 2.65 | 3.37 | 6.11 | 7.51 | |||
| Return On Assets (ROA) | -168.14% | -112.36% | -73.34% | -42.44% | -27.48% | |||
| Return On Equity (ROE) | -469.38% | -181.18% | -105.37% | -53.17% | -31.69% | |||
All data in USD , ROIC based on taxRate of 0.21